title: Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect.
authors.affiliation: From Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.R.P., J.P.P.); and Duke Center for Atrial Fibrillation, Duke University, Durham, NC (J.P.P.).
authors.forename: Manesh R
authors.initials: MR
authors.lastname: Patel
authors.affiliation: From Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.R.P., J.P.P.); and Duke Center for Atrial Fibrillation, Duke University, Durham, NC (J.P.P.). jonathan.piccini@duke.edu.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini
mesh_terms: D001281:Atrial Fibrillation / Q000453:epidemiology* / Q000401:mortality*; D005260:Female; D017052:Hospital Mortality / Q000639:trends*; D006801:Humans; D008297:Male; D006435:Renal Dialysis / Q000401:mortality*; D020521:Stroke / Q000453:epidemiology* / Q000401:mortality*
keywords: Editorials; anticoagulants; atrial fibrillation; clinical trial; kidney diseases